BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22318153)

  • 1. The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.
    Pratt ZL; Zhang J; Sugden B
    J Virol; 2012 Apr; 86(8):4380-93. PubMed ID: 22318153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
    D'Souza B; Rowe M; Walls D
    J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.
    Terrin L; Dal Col J; Rampazzo E; Zancai P; Pedrotti M; Ammirabile G; Bergamin S; Rizzo S; Dolcetti R; De Rossi A
    J Virol; 2008 Oct; 82(20):10175-87. PubMed ID: 18684838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
    Fries KL; Miller WE; Raab-Traub N
    J Virol; 1996 Dec; 70(12):8653-9. PubMed ID: 8970991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
    Mainou BA; Everly DN; Raab-Traub N
    J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
    Franken M; Devergne O; Rosenzweig M; Annis B; Kieff E; Wang F
    J Virol; 1996 Nov; 70(11):7819-26. PubMed ID: 8892903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
    Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
    PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
    Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
    Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
    Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
    Guasparri I; Bubman D; Cesarman E
    Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy.
    Lee DY; Sugden B
    Oncogene; 2008 May; 27(20):2833-42. PubMed ID: 18037963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Latent Membrane Protein 1 (LMP1).
    Kieser A; Sterz KR
    Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
    D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
    J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
    Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
    Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.